Stryker sets its sights on Utah expansion

By Catherine Sturman
Share
Established in Salt Lake City since 2011, situated in over 100 countries worldwide and accumulating over $11 billion in annual sales in 2016, medical te...

Established in Salt Lake City since 2011, situated in over 100 countries worldwide and accumulating over $11 billion in annual sales in 2016, medical technology company Stryker is set to expand its manufacturing capabilities in Utah.

Adding over 500 new jobs within 10 years, the development will enable the accumulation of over $16 million in new state revenue and will bring approximately $100 million in capital investment. This year, the company gained fifth spot on Fortune Magazine’s “World’s Most Admired Companies” on its list of the “Medical Equipment Industry.”

Its facility in Utah will continue to manufacture orthopaedic, spinal and endoscopic products, but now encompass a growing research and development focus, expanding its portfolio within the life science industry.

Related stories

It will also see the wages for staff to exceed over 100% of the average wage in the region.

“Since the establishment of Stryker in Utah, we’ve benefited from the talented workforce and first-rate education, research, and healthcare facilities in the area,” commented Mark Paul, President of Stryker’s neurovascular division. “We are excited to continue our expansion of Stryker’s operations and partner with state and local government in the future.”

Theresa Foxley, president and CEO of the Economic Development Corporation of Utah also said: “Stryker has cemented itself as a leader in global innovation and medical device manufacturing. With their continued expansion in Utah, Stryker adds to an already recognised and established life sciences and medical device manufacturing hub.”

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma